Sort
21,281 grants matching “influenza”
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$622,866Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population
$622,584Johanna Patricia Daily · Albert Einstein College Of Medicine · R01 · FY2025 · NS
Modulation of Viral Antigen Presentation in the Lung
$622,562Anna Karolina Palucka · Jackson Laboratory · U19 · FY2019 · AI
Structure and Replication of Hepatitis Delta Virus
$622,504Institute For Cancer Research · R01 · FY2005 · AI
Inflammatory dysregulation of vaccine responses in sickle cell disease
$622,447Ruth R Montgomery · Yale University · U19 · FY2024 · AI
The Immune Response to Pathogens is Controlled by the Cytokine-Induced Epigenetics Signature
$622,292Steven Lynn Kunkel · University Of Michigan At Ann Arbor · R56 · FY2017 · AI
Generation of antigen-specific regulation T cells
$622,289Harald Von Boehmer · Dana-Farber Cancer Inst · R37 · FY2011 · AI
Self-Testing Options in the era of Primary HPV screening for cervical cancer: the STEP trial
$622,109Beverly Beth Green · Kaiser Foundation Research Institute · R01 · FY2021 · CA
Lipid nanoparticles as novel adjuvants inducing effective T follicular helper cell and humoral immune responses
$622,103Norbert Pardi · University Of Pennsylvania · R01 · FY2020 · AI
Infectious Diseases/Basic Microbial Pathogenic Mechanisms
$622,090Daniel E Goldberg · Washington University · T32 · FY2012 · AI
Determinants of H. influenzae Virulence in Otitis Media
$622,078Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · DC
Repertoire studies of human antibodies to RSV and MPV F
$621,866Theodore S Jardetzky · Stanford University · R01 · FY2021 · AI
Understanding human antibody responses to chronic viral hepatitis C
$621,806Mansun Law · Scripps Research Institute, The · R01 · FY2022 · AI
Understanding human antibody responses to chronic viral hepatitis C
$621,806Mansun Law · Scripps Research Institute, The · R01 · FY2023 · AI
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
$621,751Frances Eun-Hyung Lee · Emory University · U01 · FY2022 · AI
A three-population three-scale social network model to assess disease dispersion
$621,703Ling Bian · State University Of New York At Buffalo · R01 · FY2015 · GM
University of Washington Vaccine and Treatment Evaluation Unit
$621,600Anna Wald · University Of Washington · UM1 · FY2022 · AI
MACROMOLECULAR STRUCTURE DETERMINATION - GENERAL USERS
$621,537Robert M Sweet · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2008 · RR
Understanding and targeting fibroblast activation in influenza-triggered lung inflammation and post-viral disease
$621,375David Fielding Boyd · University Of California Santa Cruz · R01 · FY2025 · HL
Generation of antigen-specific regulation T cells
$621,261Harald Von Boehmer · Dana-Farber Cancer Inst · R37 · FY2009 · AI
High-Throughput Molecular Profiling Core
$621,129Martin Thomas Ferris · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury
$620,850Eva Nozik Grayck · University Of Colorado Denver · R01 · FY2014 · HL
Development of innovative therapeutics for otitis media
$620,829Jian-Dong Li · Georgia State University · R01 · FY2018 · DC
Mechanistic evaluation of the role of circadian rhythms in acute lung injury and subsequent recovery
$620,762Shaon Sengupta · Children'S Hosp Of Philadelphia · R01 · FY2023 · HL
Lung leukocytes promote alveolar epithelial regeneration after severe injury
$620,391Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2021 · HL